Name | Tandutinib (MLN518) | CAS# | 387867-13-2 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
Tandutinib (MLN518, CT53518) is a potent FLT3 antagonist with IC50 of 0.22 μM, also inhibits PDGFR and c-Kit, 15 to 20-fold higher potency for FLT3 versus CSF-1R and >100-fold selectivity for the same target versus FGFR, EGFR and KDR. Phase 2. |
Get all suppliers by the below link:
2024-07-15 |
Tandutinib (MLN518)
Price: Inquiry |
2020-01-06 |
Tandutinib(MLN518)
Price: $500.0 |
2025-09-17 |
Tandutinib (MLN518)
Price: ¥Inquiry |
2018-05-13 |
Tandutinib (MLN518)
Price: ¥Inquiry |
2021-05-10 |
Tandutinib (MLN518)
Price: ¥Inquiry |
2017-11-14 |
Tandutinib (MLN518)
Price: ¥Inquiry |
2023-09-14 |
Tandutinib
Price: ¥Inquiry |
2024-01-30 |
Tandutinib (MLN518)
Price: ¥Inquiry |
2017-08-07 |
Tandutinib (MLN518)
Price: ¥Inquiry |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved